Skip to main content
2026 ASCRS Annual Scientific Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
CME
CME
Invitation/Ticketed Event
Invitation/Ticketed Event
Invited Lectureship
Invited Lectureship
Award Recipient
Award Recipient
Live Streamed Session
Live Streamed Session
Nurses Contact Hours
Nurses Contact Hours
Self-Assessment
Self-Assessment
Live Q&A and Polling
Live Q&A and Polling
Social
Social
Industry
Industry
Meet the Professor

Malignancy

Anorectal

APP
MTP

Meet the Professor Breakfast: MTP-S2 HRA/Dysplasia- SOLD OUT

Sunday, May 10, 2026
6:45 AM - 7:45 AM ET

Invitation/Ticketed Event CME

    Ask the Experts Discussion Leader(s)

  • Stephen Goldstone, MD (he/him/his)

    RETIRED ASSISTANT CLINICAL PROFESSOR OF SURGERY
    ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
    Icahn School of Medicine at Mount Sinai
    Amagansett, NY, United States

    All of the relevant financial relationships listed below have been mitigated.
    Linkinvax: Consultant (Terminated, August 1, 2024); Merck and Co: Advisor or Review Panel Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Honoraria (Ongoing); THD America: Consultant (Ongoing), Honoraria (Ongoing), Teaching (Ongoing)

  • Robert Goldstone, MD

    Assistant Professor of Surgery
    Massachusetts General Hospital
    Harvard Medical School
    Boston, MA, United States

    All of the relevant financial relationships listed below have been mitigated.
    This individual has no relevant relationships with ineligible companies.

Registration is required. You will confirm your place by selecting this Meet the Professor under the “Event Fee” option while registering.

CME: 1 hour

We will be discussing issues that participants have related to diagnosis of HPV related anal disease including high-grade dysplasia, condyloma and complex presentations. We will discuss practice related issues as well as implementing the anal cancer screening guidelines. We encourage attendees to bring to the group cases they have questions about any cases or issues they are experiencing.

Learning Objectives:

Upon completion of this activity, participants should be able to:
  • Explain the anal cancer screening guidelines .
  • Recognize options for developing anal cancer screening in your type of practice.
  • Describe follow-up guidelines for patients you've treated for anal cancer or anal dysplasia.